Jans Fromow-Guerra
Overview
Explore the profile of Jans Fromow-Guerra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Esteban Macineira E, Bande M, Soberanes-Perez J, Paniagua L, Golzarri M, Fromow-Guerra J, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274205
The aim of this study was to investigate endogenous endophthalmitis (EE) in Spain and Mexico, focusing on microbial patterns, antibiotic resistance, infection sources, risk factors, and patient outcomes. Over 20...
2.
Velez-Montoya R, Osorio-Landa H, Franco-Ramirez K, Martinez-Pacheco V, Ramirez-Estudillo J, Rosales-Padron J, et al.
Int J Retina Vitreous
. 2024 Jul;
10(1):53.
PMID: 39075569
Background: To report the risk of exudation recurrence and long-term outcomes in patients with choroidal neovascularization secondary to angioid streaks, according to its morphology and characteristics by optical coherence tomography...
3.
Rodriguez-Castro S, Fromow-Guerra J, Garza-Gonzalez S, Pinilla-Monroy A, Soberon V
Retin Cases Brief Rep
. 2024 Jan;
19(2):228-231.
PMID: 38232342
Purpose: To report our findings in a patient with presumed Kikuchi-Fujimoto disease. Methods: Report of clinical findings, fundus images, optical coherence tomography, and ultrasonography. Results: A 19-year-old female patient who...
4.
Velez-Montoya R, Monroy-Esquivel L, Ortiz-Guevara R, Quiroz-Mercado H, Fromow-Guerra J
Retina
. 2023 Mar;
43(9):1433-1447.
PMID: 36893433
Purpose: To organize, categorize, and create a quick reference guide for the use of intravitreal antibiotic alternatives to the standard combination of vancomycin and ceftazidime for the treatment of endophthalmitis....
5.
Velez-Montoya R, Rivera-Cortes M, Ledesma-Gil G, Carranza-Casas M, Martinez J, Levine H, et al.
Cornea
. 2022 Nov;
42(7):805-814.
PMID: 36441843
Purpose: The purpose of this study was to assess the role of combined surgical treatment of therapeutic penetrating keratoplasty and pars plana vitrectomy in the anatomical and functional outcome of...
6.
Wu L, Bordon A, Charles M, Rodriguez F, Lee J, Machewitz T, et al.
Int J Retina Vitreous
. 2022 Oct;
8(1):76.
PMID: 36258240
Background: AQUILA (NCT03470103) was a prospective, observational, 12-month cohort study evaluating treatment patterns, clinical effectiveness, and safety of intravitreal aflibercept (IVT-AFL) in patients from Latin America with neovascular age-related macular...
7.
Rodriguez F, Wu L, Bordon A, Charles M, Lee J, Machewitz T, et al.
Int J Retina Vitreous
. 2022 Aug;
8(1):52.
PMID: 35918743
Background: AQUILA (NCT03470103) was a prospective, observational, 12-month cohort study to understand treatment patterns and to evaluate the clinical effectiveness and safety of intravitreal aflibercept (IVT-AFL) in patients from Latin...
8.
Ramos-Betancourt N, Field M, Davila-Alquisiras J, Karp C, Hernandez-Zimbron L, Garcia-Vazquez R, et al.
Ocul Surf
. 2020 Jul;
18(4):627-632.
PMID: 32717381
Purpose: To determine genetic mutational profiles in patients with Ocular Surface Squamous Neoplasia (OSSN) using whole exome sequencing. Methods: Prospective, case-series study. Patient recruitment was conducted in a single tertiary...
9.
Hernandez-Da Mota S, Melo-Granados E, Fromow-Guerra J, Bejar-Cornejo F, Gallego-Pinazo R, Rodriguez-Ayala E
Eur J Ophthalmol
. 2019 Mar;
29(3):271-277.
PMID: 30841748
Purpose: The aim of this study was to evaluate the correlations between fundus autofluorescence and morphologic parameters as well as visual function in patients with diabetic macular oedema treated with...
10.
Fromow-Guerra J, Chirino-Sprung R, Landetta-Garcia J
Med Confl Surviv
. 2019 Feb;
34(4):309-312.
PMID: 30784303
No abstract available.